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Abstract 
Neonatal herpes is a significant yet preventable outcome of genital herpes exposure. 
Approximately 1,500-2,000 new cases of neonatal herpes infection are diagnosed annually (Ural 
& Cheng Peng, 2013). The purpose of this project is to increase the knowledge of health care 
professionals about genital herpes and its prevention, so that the general public can become 
better informed. Ultimately, the hope is that by increasing the general public’s awareness about 
genital herpes and its prevention, genital herpes acquisition in pregnancy will be decreased, thus 
reducing cases of neonatal herpes. The educational intervention Neonatal Herpes Prevention: 
Management Strategies During Pregnancy combines lecture and interactive formats and is 
intended for use during an educational meeting. The envisioned use for the educational 
intervention is a continuing education course, specifically among health care professionals caring 
for pregnant women or women of childbearing age. The literature suggests that in-person 
educational meetings, web-based educational modules, and printed educational materials are all 
effective at improving professional practice among health care providers. Thus, the educational 
content is designed for adaptation to various educational methods in order to meet the diverse 
educational needs and learning style preferences of health care providers. The anticipated 
outcome is a reduction in occurrences of neonatal herpes as a result of increased awareness 
among providers, patients and the general public, behavioral changes regarding sex practices, 
and improved management of genital herpes.       
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Management Strategies During Pregnancy to Prevent Neonatal Herpes:  
An Educational Intervention for Health Care Providers  
 The risk of maternal transmission of herpes simplex virus (HSV) to the newborn is a 
significant health concern. One in five American women is infected with the herpes virus and 
about 2% of women acquire genital herpes during pregnancy (Ural & Cheng Peng, 2013; Wood, 
2011). Neonatal transmission is highest among women who are seronegative because there is not 
adequate time to develop antibodies needed to suppress viral replication prior to labor (Straface, 
2012; Ural & Cheng Peng, 2013).  Therefore, the possibility of transmission to the neonate is 
highest (30-50%) among pregnant women who acquire genital herpes close to the time of 
delivery (Centers for Disease Control and Prevention [CDC], 2011b). Among women acquiring 
genital herpes during pregnancy, two-thirds remain asymptomatic and have no symptoms 
suggestive of a genital herpes infection (Kimberlin & Baley, 2013). Furthermore, 60% to 80% of 
women who deliver a baby infected with herpes have neither a past history of infection nor a 
sexual partner reporting a history (Kimberlin & Baley, 2013). This considerable risk of unknown 
genital herpes transmission from the pregnant mother to the neonate indicates a need for 
preventive action.  
The Current Situation 
 Neonatal HSV is defined as infection in a newborn in the first 28 days of life (Corey & 
Wald, 2009). The frequency of neonatal herpes is estimated to be about 10-60 cases per 100,000 
live births in the United States (U.S.) (Jaiyeoba, Amaya, Soper, & Kilby, 2012). Untreated 
neonatal HSV infection is associated with a mortality rate of 60%, and even with prompt 
treatment, survivors experience great disability (Ural & Cheng Peng, 2013). Severe cases can 
lead to lifelong complications; thus, prevention is the basis for decreasing the negative effects of 
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herpes in the neonate (Woods, 2011). Prevention of neonatal herpes depends on preventing 
initial acquisition of genital herpes infection during late pregnancy, recognizing asymptomatic 
infections, and avoiding exposure of the infant to herpetic lesions during delivery (CDC, 2011b; 
Ural & Cheng Peng, 2013).  
In the framework of childbirth, the risks of genital herpes are frequently misunderstood 
(Kriebs, 2008). Studies conducted by Handsfield, Stone, and Graber (1998), and Romanowski, 
Zdanowicz, and Owens (2008) found that knowledge regarding genital herpes was low among 
health care providers and those with herpes themselves. Hence, many infected persons and their 
sex partners, as well as others at risk, were receiving suboptimal and insufficient health care 
information and prevention guidance (Handsfield et al., 1998). Education and counseling for 
women without known genital herpes, as well as for those known to be infected and their sex 
partners, are recognized as key components in the prevention of sexual and perinatal 
transmission of HSV (Glass, Nelson, & Huffman, 2005). This highlights a need for educational 
efforts aimed at health care providers. By equipping health care professionals with the 
knowledge necessary to educate and counsel patients, the general public will become better 
informed about genital herpes and its prevention in order to minimize transmission of HSV.  
Background 
 In order to fully understand the problem of genital herpes and its effect on pregnancy and 
childbirth, background information is included about HSV, including transmission, clinical 
manifestations, infection statuses, risk factors, diagnostic testing, and antiviral therapy. To allow 
for a better understanding of the disease’s implications on the expectant woman and neonate, 
material regarding HSV during pregnancy and neonatal herpes is also presented.     
Herpes Simplex Virus (HSV)  
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The HSVs, herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-
2), members of a broad group of DNA viruses, are transferred across epithelial mucosal cells and 
skin breaks, migrating to nerve tissues where they lie dormant in a latent stage (Kriebs, 2008). 
This latent stage allows the virus to cause disease reoccurrences of varying severity over the 
entirety of an individual’s life (Jaiyeoba et al., 2012). HSV-1 infections prevail in orofacial 
lesions, typically located in the trigeminal ganglia (Kriebs, 2008).  Hence, HSV-1 is a common 
chronic infection that is the cause of most oral herpes, or cold sores (CDC, 2011a). On the other 
hand, HSV-2 infection is usually found in the lumbosacral ganglia (Kriebs, 2008). Nonetheless, 
either virus can infect any region of the body, meaning HSV-1 and HSV-2 can both cause genital 
herpes (Kriebs, 2008).  
There is no cure for HSV and living with herpes can be a difficult adjustment (Office on 
Women’s Health, United States Department of Health and Human Services [HHS], 2009; 
ACOG, n.d.). Different from other incurable diseases, HSV is not typically linked to a long-term 
deterioration in health (Kriebs, 2008). However, a new HSV diagnosis frequently creates stress, 
embarrassment, and concerns about future sexual encounters as well as the safety of childbearing 
(Kriebs, 2008).    
Transmission and clinical manifestations. HSV is spread through direct contact with 
lesions, typically during sexual activity (Kriebs, 2008; ACOG, n.d.). Lesions may appear 2-14 
days after exposure and may persist for 2-4 weeks without antiviral therapy (Glass et al., 2005; 
ACOG, n.d.). Lesions present as small, tender, fluid-filled vesicles on the genitals, buttocks, or 
other areas (Glass et al., 2005). Other symptoms may include intense pain, dysuria, itching, 
lymphadenopathy, fever, headache, nausea, malaise, and myalgia (Glass et al., 2005). While 
lesions heal in days or weeks, the virus remains in the body (ACOG, n.d.). Transmission can also 
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occur when a sore is not present, known as asymptomatic viral shedding, because intermittent 
viral reactivation occurs both during periods of active outbreaks and when no symptoms are 
present (Kriebs, 2008; ACOG, n.d.). There is a high possibility that HSV-infected individuals are 
unaware of their diagnosis because up to 70% of heterosexual transmission happens during 
periods of asymptomatic shedding (Kriebs, 2008).   
Infection status. Three statuses of infection exist for HSV, classified as primary, non-
primary first-episode, and recurrent infection.  
Primary infection. Primary infection occurs when an individual is initially exposed to 
HSV and antibodies do not exist at the time of infection (Glass et al., 2005). Nearly 75% of 
people with primary infection are asymptomatic (Glass et al., 2005). This is the most significant 
HSV infection when considering pregnancy as rates of neonatal herpes may be as high as 50% 
(Anzivino et al., 2009; Kriebs, 2008).         
 Non-primary first-episode infection. Non-primary first-episode infection occurs when an 
individual with preexisting antibodies to either HSV-1 or HSV-2 experiences a first episode with 
the opposite HSV type (Straface et al., 2012).   
 Recurrent infection. Recurrent infections occur in someone with preexisting antibodies 
against the same HSV type and may be symptomatic or asymptomatic (Glass et al., 2005; 
Straface et al., 2012). Antibodies to HSV do not prevent recurrences (Glass et al., 2005). When 
symptoms occur, they are typically localized with lesions present for roughly seven days (Glass 
et al., 2005). An outbreak is often preceded by a prodrome when an individual may feel pain in 
the lower back, buttocks, thighs, or knees (ACOG, n.d.). Recurrent infections are associated with 
only a 3% risk of neonatal herpes because transplacental antibodies significantly decrease the 
risk of transmission (Jaiyeoba et al., 2012; Kriebs, 2008).      
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Risk factors. The HSV-2 antibody is closely linked to female gender, years of sexual 
activity, number of lifetime sexual partners, and past infection with STDs (Glass et al., 2005). 
The prevalence of HSV infection rises with age, reaching its maximum around 40 years of age 
(Straface et al., 2012). Such high rates among adults in that age group can be attributed to the 
chronic nature of the virus as well as fluctuating sexual relationships over time (Kriebs, 2008). 
There is minimal risk of infection from a single sexual encounter, so when a partner is infected, 
longer-term relationships increase the potential for heterosexual transmission (Kriebs, 2008). 
Additional independent predictors of HSV-2 infection include less education (defined by last 
year of education completed), lower-income, and the use of cocaine (Glass et al., 2005).   
 Diagnostic testing. Diagnostic testing options for HSV include polymerase chain 
reaction, viral culture, and serology blood testing.  
Polymerase chain reaction. Polymerase chain reaction (PCR) is a molecular test that 
examines the patient’s blood for pieces of the virus’ DNA (WebMD, 2014). This test is able to 
identify viral shedding in the presence or absence of lesions (Kriebs, 2008). When available, this 
detection method should be considered because of its speed, accuracy, and ability to distinguish 
HSV-1 from HSV-2 (American Sexual Health Association [ASHA], 2014b).  
Viral culture. Viral culture relies on fluid collected from intact blisters and is most 
accurate early in the sequence of clinical outbreak (Kriebs, 2008). A culture should be obtained 
within the first 48 hours after a lesion appears (ASHA, 2014b). Results are typically available 
within a week of the culture date (ASHA, 2014b).  
Serology blood testing. Serology blood tests are able to detect previous HSV-1 or HSV-2 
infection in asymptomatic individuals, or diagnose symptomatic individuals when a culture is not 
possible or the clinical syndrome is indistinct (Glass et al., 2005). Serology testing identifies 
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prior exposure through the presence of antibodies, but is unable to determine the onset of 
infection or pinpoint the locus of shedding (Kriebs, 2008).  
 Antiviral therapy. Acyclovir, famciclovir, and valacyclovir have been approved for the 
treatment of genital herpes (Glass et al., 2005). These drugs act by inhibiting viral replication in 
cells infected with HSV, minimizing the length of an outbreak (Glass et al., 2005; ACOG, n.d.). 
Daily medication use can significantly decrease the risk of transmission in individuals 
experiencing frequent outbreaks (ACOG, n.d.). Primary herpes infections require a prolonged 
treatment regimen because antibodies that normally help to reduce symptoms have not yet been 
established (Kriebs, 2008). In this case, a 10-day course of oral antiviral medication is suggested 
(Kriebs, 2008). A shorter course of antiviral medication is warranted for recurrent infections 
(Kriebs, 2008).  
Herpes Simplex Virus in Pregnancy 
 Genital herpes during pregnancy has significant implications for the pregnant woman 
and, thus, the neonate. Initial acquisition during pregnancy, or primary infection, is less prevalent 
than recurrent infection, yet primary infection has a significantly higher transmission rate 
(USPSTF, 2005b). This is important because, during pregnancy, primary infection poses greater 
threats to both mother and infant than recurrent infection, regardless of the presence of 
symptoms (Kriebs, 2008). Primary infections in the first trimester are related to higher rates of 
spontaneous abortion and stillbirth, while infections acquired later in pregnancy may result in 
premature birth and an infant with low birth weight (Perinatology, n.d.). Additionally, the 
majority of infants who acquire neonatal herpes are born to asymptomatic mothers lacking 
histories of clinically evident genital herpes (CDC, 2011b). Among all asymptomatic women 
discovered to be shedding HSV at the time of delivery with no known history of genital herpes, 
MANAGEMENT STRATEGIES DURING PREGNANCY  9 
about one-third have a primary infection and are thus at an increased risk of transmitting 
infection to the neonate (Jaiyeoba et al., 2012).  Hence, in order to prevent neonatal herpes, it is 
essential to prevent acquisition of primary infection during pregnancy, as well as transmission to 
the neonate from women experiencing asymptomatic infection.          
Risk factors. Maternal age of 21 years and younger is associated with a high risk for 
vertical transmission (Ural & Cheng Peng, 2013). Similarly, uninfected women in serodiscordant 
relationships, where the partner is infected yet the woman remains uninfected, are at high risk for 
mother-to-child transmission (Kriebs, 2008). During pregnancy, a partner’s history of oral herpes 
has been associated with an increased risk of a seronegative woman acquiring HSV-1; though 
having a new partner within the past year has been linked to HSV-2 acquisition (Kriebs, 2008).  
Neonatal Herpes Simplex Virus  
It is imperative to have an understanding of neonatal HSV and its severity in order to 
recognize the importance of its prevention. Manifestations of the herpes virus in the neonate 
range from mild localized disease to severe disseminated infection (USPSTF, 2005b). Delayed 
diagnosis is associated with high mortality and even with adequate treatment, permanent 
consequences including cerebral palsy and developmental delays may occur (Jaiyeoba et al., 
2012). The overall death rate from untreated neonatal herpes is 65% (Jaiyeoba et al., 2012). This 
emphasizes that prevention and early recognition of exposure are of extreme importance in 
reducing the morbidity and mortality associated with neonatal HSV (Jaiyeoba et al., 2012).   
Neonatal transmission. The herpes infection may be transmitted from the pregnant 
woman to the infant before, during, or after delivery, otherwise known as intrauterine, 
intrapartum, and postnatal transmission (Ural & Cheng Peng, 2013).      
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Intrauterine. Intrauterine, also known as congenital, infections are very rare (1/100,000) 
due to the acquisition of the virus in utero (Straface et al., 2012). Intrauterine infections occur 
without the baby passing through the vagina, such as if the amniotic sac breaks a few hours 
before birth (ACOG, n.d.; USPSTF, 2005b). Congenital infection is distinguished from neonatal 
HSV infection based on the appearance of lesions, with neonatal herpes lesions becoming 
apparent more than 48 hours after birth (Straface et al., 2012).  Intrauterine transmission has been 
known to occur in pregnant women who develop disseminated HSV infections (Straface et al., 
2012). According to Straface et al. (2012), in utero transmission is most likely during the first 20 
weeks of gestation, and results in abortion, stillbirth, and congenital anomalies.  
Intrapartum. Intrapartum transmission accounts for the majority of neonatal infections 
(Ural & Cheng Peng, 2013). Risk is lessened when protective maternal antibodies cross from 
mother to neonate and exist in the fetus (Ural & Cheng Peng, 2013). Hence, when the mother 
acquires a primary infection, transmission rate is 50%, compared to a transmission rate of 33% 
with non-primary first-episode infection, and a transmission rate of 0-4% with recurrent infection 
(Ural & Cheng Peng, 2013). Among intrapartum infections, 80% occur in women who have no 
reported history of infection (Horsley, 2008).   
Postnatal. Postnatal transmission accounts for 5-10% of neonatal HSV infections and 
occurs through infant contact with infected parents or health care providers (Straface et al., 2012; 
Ural & Cheng Peng, 2013). For example, although HSV is not passed to the baby through breast 
milk, it is possible for the infant to become infected by touching a lesion located on the mother’s 
breast (ACOG, n.d.).   
Types of neonatal infection. Three types of neonatal HSV infection acquired during the 
intrapartum or postpartum period have been identified (Kimberlin & Baley, 2013).  
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Disease localized to the skin, eyes, and mouth (SEM). The most prevalent (45%) and 
nonthreatening type of neonatal herpes infection is disease localized to the skin, eyes, and mouth 
(SEM) (Ural & Cheng Peng, 2013). This type is characterized by vesicular lesions isolated to the 
skin, eye, and mucosal areas (Jaiyeoba et al., 2012). Serious SEM infections may lead to death or 
long-term central nervous system (CNS) morbidity, but the majority of affected infants do not 
have CNS or multiple organ involvement and therefore have more favorable long-term outcomes 
if treatment is not delayed (Jaiyeoba et al., 2012; Ural & Cheng Peng, 2013).  
Encephalitis with or without SEM involvement. The second type, referred to as 
encephalitis with or without SEM involvement, also called CNS disease, affects about 30% of 
infants who acquire neonatal HSV. CNS disease is associated with a worse prognosis (Jaiyeoba 
et al., 2012).  
Disseminated disease. Disseminated disease, which affects 25% of infants with neonatal 
herpes, involves numerous organs, including the CNS, lungs, liver, adrenal, and/or SEM, and is 
associated with the highest mortality rate of over 50% even with treatment (Glass et al., 2005; 
Kriebs, 2008). Infants who survive often suffer from significant neurologic deficits, blindness, 
seizures, and learning disabilities (Kriebs, 2008).  
Review of Literature  
 A variety of strategies exist to prevent and manage genital herpes infection during 
pregnancy in order to avoid the outcome of neonatal herpes. These strategies include assessment, 
screening, antiviral therapy, cesarean delivery, and education and counseling. However, 
numerous features of HSV infections, including high prevalence among pregnant women yet rare 
perinatal transmission, unpredictable relapses, and the likelihood of undiagnosed, asymptomatic 
infections, make prevention of neonatal transmission a challenge (Jaiyeoba et al., 2012).  
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Assessment 
 All women should be assessed for a history of HSV infection early in pregnancy (Money 
& Steben, 2008; USPSTF, 2005b). A woman’s partner history should also be evaluated at the 
first prenatal visit (Straface et al., 2012). Women with a history of genital herpes should be asked 
about recent symptoms and should also have a perineum examination performed prior to delivery 
(USPSTF, 2005b). This includes a careful inspection of the vulva, vagina, and cervix while 
avoiding artificial rupture of membranes (Anzivino et al., 2009). Similarly, the CDC (2011b) 
suggests that at the onset of labor all women are both questioned regarding symptoms of genital 
herpes, including prodromal symptoms, and examined for herpetic lesions. Nonetheless, 
screening via assessment and physical examination alone is unreliable because viral shedding 
without clinically visible genital lesions is common (Jaiyeoba et al., 2012). Although this 
remains the focus of clinical practice, it has not reduced the incidence of neonatal herpes because 
detection of HSV in the genital tract at the time of delivery is a more significant finding than any 
prior history (Jaiyeoba et al., 2012).   
Screening 
 “There is no recommendation for universal screening for HSV during pregnancy” 
(Kriebs, 2008, p. 206). The U.S. Preventive Services Task Force (USPSTF, 2005a) 
“recommends against routine serological screening for herpes simplex virus (HSV) in 
asymptomatic pregnant women at any point during pregnancy to prevent neonatal HSV 
infection.” Fair evidence was found that screening asymptomatic pregnant women does not 
reduce transmission of HSV to newborns (USPSTF, 2005b). Women developing primary 
infection during pregnancy, with the highest risk of transmitting infection to the neonate, are 
initially seronegative (USPSTF, 2005b). Thus, serology screening tests for HSV do not 
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accurately detect those at highest risk for mother-to-baby transmission (USPSTF, 2005b). ACOG 
(2007) also does not recommend routine screening of pregnant women, including asymptomatic 
women with recurrent disease. The CDC (2011c) agrees that if no lesions are present during the 
third trimester in pregnant women with a history of recurrent infection, routine cultures are not 
indicated.  
However, the CDC (2013b) does recommend testing pregnant women, at any time during 
pregnancy, who present with symptoms or have a partner with genital herpes or symptoms 
indicative of genital herpes. Kimberlin and Baley (2013) and Jaiyeoba et al. (2012) suggest that 
women in labor with visible genital lesions indicative of HSV undergo type-specific serology 
testing through HSV PCR, and viral culture. Straface et al. (2012) and Anzivino et al. (2009) 
recommend sequential viral cultures on genital secretions beginning at 32 weeks gestation when 
a primary infection is acquired during the first two trimesters. Thus, screening for HSV has 
implications during pregnancy in symptomatic women, women with symptomatic partners, and 
among women acquiring primary infection early in pregnancy. On the contrary, screening alone 
is not likely to be successful at preventing neonatal herpes since it is unable to accurately identify 
those at highest risk of transmitting infection to the neonate.     
Antiviral Therapy 
 Antiviral therapy, including acyclovir, valacyclovir, and famciclovir, is indicated for 
individuals with genital herpes infection to reduce the length of recurrences and suppress viral 
shedding, thus reducing transmission risk (CDC, 2011b; ACOG, n.d.). This is significant for 
pregnant women with genital herpes infection in order to prevent neonatal herpes. 
Recommendations have been made regarding the use of antiviral therapy in pregnant women 
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based on infection status. These recommendations and the safety of antiviral therapy during 
pregnancy are discussed in this section.  
 Primary infection during pregnancy. At the time of initial outbreak, antiviral therapy 
should be administered orally to pregnant women to decrease the duration and severity of 
symptoms and to minimize the occurrence of viral shedding (ACOG, 2007). Jaiyeoba et al. 
(2012) also recommend that all women with confirmed primary infection receive antiviral 
therapy regardless of the time of manifestation during pregnancy. Intravenous acyclovir is 
suggested for pregnant women with severe genital infections or with disseminated herpetic 
infections (ACOG, 2007). However, due to the commonality of asymptomatic primary infections 
acquired during pregnancy, antiviral therapy may not have useful implications for this 
population.       
Recurrent infection during pregnancy. In adults and adolescents with recurrent 
infection, systemic antiviral therapy effectively decreases viral shedding and recurrences of 
genital herpes and is recommended to prevent transmission of HSV (Kriebs, 2008; USPSTF, 
2005b). ACOG’s (2007) guidelines suggest the use of acyclovir and valacyclovir at 36 weeks’ 
gestation until delivery in women with active recurrent infection to prevent neonatal herpes. 
Kriebs (2008) and Money and Steben (2008) add that suppressive antiviral therapy, acyclovir or 
valacyclovir, beginning at 36 weeks’ gestation decreases the risk of herpetic lesions and viral 
shedding near term, decreases the need for cesarean delivery, and reduces cases of neonatal 
infection, even in women who have not had clinical outbreaks during pregnancy. Straface et al. 
(2012) and Anzivino et al. (2009) agree with the recommendation for acyclovir or valacyclovir 
treatment from 36 weeks’ gestation until term to reduce the potential for future clinical 
manifestations and vertical transmission, and to eliminate the virus during delivery. Still, 
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Kimberlin and Baley (2013) suggest that viral shedding is only reduced, not eliminated, and thus 
occurrences of neonatal herpes have been recently reported in infants born to women who were 
receiving suppressive antiviral therapy. Similarly, the USPSTF (2005b) has found no evidence at 
this time that antiviral therapy use in women with a history of HSV decreases the incidence of 
neonatal infection. Additionally, the CDC (2011b) suggests that the effectiveness of antiviral 
therapy use during late pregnancy to reduce neonatal herpes infections is unknown.   
Safety during pregnancy. USPSTF has found that that there is insufficient evidence 
regarding the safety of acyclovir use during pregnancy (Glass et al., 2005). The CDC (2011b) 
agrees that the safety of systemic acyclovir, valacyclovir, and famciclovir during pregnancy has 
not yet been established. However, an increased risk for major birth defects was not found in 
pregnant women being treated with acyclovir during the first trimester compared to the general 
population (CDC, 2011b). Hence, acyclovir may be administered orally to pregnant women with 
primary HSV infection or severe recurrent infection, and may be administered intravenously to 
those with severe infection (CDC, 2011b). The data pertaining to prenatal exposure to 
valacyclovir and famciclovir is scant and thus does not provide useful information on pregnancy 
outcomes (CDC, 2011b). Nonetheless, all three antiviral therapy drugs, acyclovir, valacyclovir, 
and famciclovir, have been labeled category B drugs suggesting that no teratogenic effects were 
discovered in animal studies, although no or limited studies on humans are available (Ural & 
Cheng Peng, 2013).   
Cesarean Delivery 
 Cesarean delivery is an option for pregnant women with genital herpes. 
Recommendations have been made for pregnant women with active genital herpes infection and 
for women with a history of the disease but who are asymptomatic at the time of delivery.  
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Active infection. The CDC (2011b) identifies cesarean delivery as the current standard 
among pregnant women who have active genital HSV lesions or early symptoms, such as vulvar 
pain and itching, at the time of delivery. Although cesarean delivery will not completely 
eliminate the potential for transmission of HSV to the infant, women with genital herpes lesions 
at the time of delivery should undergo a cesarean delivery in order to minimize the possibility for 
transmission (CDC, 2011b). Similarly, ACOG (2007) recommends cesarean delivery for all 
women with active genital lesions or prodromal symptoms at the time of delivery.  
The National Institute for Health and Clinical Excellence (NICE, 2011) declares there is 
ambiguity regarding the effect of cesarean deliveries on reducing the potential for transmission 
of neonatal herpes in women with recurrent infections. Similarly, the USPSTF (2005b) declares 
that there is insufficient evidence to recommend performance of cesarean deliveries in women 
with active herpes lesions at the time of delivery in order to decrease the incidence of neonatal 
herpes. A study evaluated by the USPSTF, which was designed to demonstrate the prevention of 
HSV transmission to neonates through the use of cesarean delivery, provides optimism. Among 
women who were HSV positive at the time of labor, one case of neonatal herpes was found 
among 85 cesarean deliveries, compared to 9 cases among 117 vaginal deliveries (Glass et al., 
2005). This suggests that cesarean deliveries may in fact be effective at minimizing occurrences 
of neonatal herpes infections among infants born to mothers with HSV. Nonetheless, additional 
research is indicated to further investigate the effectiveness of cesarean deliveries at minimizing 
the outcome of neonatal herpes.     
 Absence of symptoms. Women without signs or symptoms of genital herpes or its 
prodrome should be allowed to deliver vaginally (CDC, 2011b). In other words, the CDC 
(2011b) recommends against prophylactic cesarean delivery in women with no active genital 
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herpetic lesions at the onset of labor. ACOG (2007) also recommends against cesarean delivery 
for women with a history of HSV infection yet without active genital lesions during labor.   
Pregnancy-Related Procedures 
There are various interventions, such as transabdominal procedures and invasive 
monitoring, that pregnant women often undergo. It is important to review these interventions in 
the context of pregnant women with genital herpes. Transabdominal procedures, such as 
chorionic villus sampling, amniocentesis, or percutaneous umbilical cord sampling, may be 
performed on pregnant women with recurrent infection, even in the presence of herpetic lesions 
(Horsley, 2008). On the contrary, invasive monitoring, such as with the use of a fetal scalp 
electrode, significantly increases the risk for intrapartum transmission of neonatal infection 
(Horsley, 2008). Kriebs (2008) recommends that such invasive procedures be avoided if possible 
when a mother with HSV is in labor to decrease fetal exposure to vaginal secretions. Anzivino et 
al. (2009) add that fetal scalp electrode monitoring during labor and vacuum or forceps assisted 
delivery should only be implemented if necessary. Fetal scalp monitoring may be considered 
when indicated in a woman with a history of recurrent infection yet who does not have active 
lesions (Horsley, 2008). Thus, while these interventions may still be considered for use among 
pregnant women with genital herpes, it is important to weigh the risks and benefits that such 
measures may have on the neonate.     
Education and Counseling  
 Education and counseling are necessary to prevent sexual and perinatal transmission of 
HSV (Glass et al., 2005). Many women and their partners enter pregnancy without a clear 
understanding of what they can do to prevent risk to their infant (Kriebs, 2008). According to the 
American Sexual Health Association (2014a), the best way to protect one’s infant is to be 
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educated on the facts about HSV and how to protect oneself. Thus, informed educators are 
necessary to assist the woman and her partner in choosing the best course of action for their 
pregnancy (Wood, 2011). Handsfield et al. (1998) found that knowledge was low among health 
care providers, those at risk for genital herpes acquisition, the general public, and even those 
with herpes themselves regarding incidence, prevalence, transmission, neonatal herpes, and 
antiviral therapy. Romanowski et al. (2008) found that patients with genital herpes, and their 
providers, lacked knowledge regarding genital herpes diagnosis, asymptomatic shedding, and 
risk of transmission, highlighting that the findings of Handsfield et al. remain true. Thus, the 
CDC suggests that a campaign to better educate health care providers and the general public 
about genital herpes and its prevention is necessary (Handsfield et al., 1998).  
Specific educational messages. There are several important messages to convey to 
women and their partners in order to decrease sexual and perinatal transmission of genital 
herpes. The risk of neonatal herpes infection should be explained to each person, including men 
(CDC, 2011b). Education should emphasize prevention of neonatal herpes by preventing 
transmission and acquisition of genital herpes among women and their partners. According to the 
U.S. Department of Health and Human Services’ Office on Women’s Health (2009) strategies to 
lower one’s risk of acquiring genital herpes include practicing abstinence; having a faithful, 
sexual relationship with one partner who has tested negative for herpes; and condom use. It is 
also important for individuals to be knowledgeable on various forms of birth control, including 
which methods do and do not protect against HSV, as well as the symptoms of genital herpes and 
actions to take should symptoms develop (Office on Women’s Health, 2009). Individuals need to 
recognize that genital herpes is not prevented by washing the genitals, urinating, or douching 
after intercourse (CDC, 2013a). Education should stress that the most effective way to prevent 
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genital herpes is to abstain from intercourse or to only have sexual encounters with an uninfected 
individual in a monogamous relationship (CDC, 2013a).   
If symptoms characteristic of genital herpes develop, one should be instructed to: (1) seek 
medical attention and treatment immediately; (2) follow the provider’s orders and complete all 
prescribed medication regimens regardless of the disappearance of symptoms; (3) abstain from 
sexual activity while being treated and while symptoms persist; and (4) tell all sexual partners so 
they, too, can receive treatment (Office on Women’s Health, 2009). If a pregnant woman’s 
partner has genital herpes, she should: (1) get tested to find out if she, too, is infected; (2) avoid 
sexual activity beginning at the onset of prodromal symptoms, while the partner is being treated 
or if symptoms persist, and until a few days after the lesions have disappeared; and (3) use 
condoms correctly and consistently (Office on Women’s Health, 2009; ACOG, n.d.). Lesions 
and secretions should not come into contact with another individual’s skin and if this happens, 
one should wash their hands with soap and water to prevent self-reinfection as well as 
transmission to others (ACOG, n.d.).  
Condom use. The use of condoms is recommended throughout pregnancy to prevent 
genital herpes transmission, even if the male partner has no active lesions (Straface et al., 2012). 
Condoms reduce the potential for transmission if used correctly and consistently though areas 
unprotected by the condom may still become infected (CDC, 2013a). Thus, since condoms are 
not a complete barrier for the genital region, even regular condom use does not eliminate all 
possibility of transmission (Kriebs, 2008).  
 Counseling. Though initial counseling provided at the first visit is advantageous, several 
patients benefit from learning about the chronic aspects of HSV after the acute illness subsides 
(CDC, 2011b). Counseling should reflect the fact that, during pregnancy, new HSV infections 
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carry greater risks for both mother and child than does recurrent shedding, whether or not 
symptoms are present (Kriebs, 2008). Specifically, women with known recurrent infections 
should be counseled at the time of delivery about the risks of transmission to the neonate (Money 
& Steben, 2008). Women need to recognize that even if they have no or rare clinical recurrences, 
there still exists a small risk of intrapartum transmission (Kriebs, 2008). Corey and Wald (2009) 
emphasize the need to counsel all women to abstain from unprotected sexual intercourse, 
including oral-genital contact, in late pregnancy. Pregnant women not known to be infected with 
genital herpes should be counseled to abstain from intercourse, including oral and vaginal 
contact, during the third trimester of pregnancy with men who have HSV (CDC, 2011b). 
Breastfeeding mothers should be instructed not to breastfeed if lesions are present on the breast, 
including the nipple (ACOG, n.d.). Milk may still be pumped or expressed by hand yet milk that 
comes into contact with sores while pumping should be discarded (ACOG, n.d.).       
 Corey and Wald (2009) identify changes in sexual behavior of pregnant women at risk, a 
universal and low cost strategy, as the key to reducing acquisition of HSV during pregnancy. In 
order for behavior changes to occur, patients must be knowledgeable on genital herpes, its 
implications during pregnancy, and the disease’s effect on the neonate should perinatal 
transmission occur. Providers can best care for their patients by guaranteeing that women and 
their partners receive accurate information about “the transmission and diagnosis of herpes 
simplex, prevention of neonatal disease, and available management strategies” (Kriebs, 2008, p. 
207).  
Management Strategies  
Several strategies exist to educate pregnant women identified as at risk for acquiring 
HSV. However, it would prove difficult to target individuals in need of education based solely 
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on the identified risk factors that increase one’s chance of acquiring genital herpes. A 
population-based study using Washington State’s data on neonatal HSV infection indicated that 
demographic and clinical characteristics could not be used to identify women with high risk of 
transmitting HSV to their infants (Mark, Kim, Wald, Gardella, & Reed, 2006). This suggests that 
targeting education toward women at risk for acquiring genital herpes during pregnancy is not 
likely to be successful, indicating a need to educate the general public. Health care providers 
play a vital role in educating the general public on a health related issue, such as genital herpes. 
Studies by Handsfield et al. (1998) and Romanowski et al. (2008) found that knowledge was low 
among health care providers regarding genital herpes, indicating that health care providers 
should instead be the target of educational interventions. By educating health care providers, 
they will become equipped to appropriately counsel and educate their patients on genital herpes 
and its prevention, particularly during pregnancy. Counseling and promoting sexual health 
regarding genital herpes among all patients will increase the general public’s awareness about 
genital herpes and its prevention, ultimately decreasing genital herpes acquisition in pregnancy, 
and minimizing cases of neonatal herpes. 
Patient-Physician Gap  
According to the American Sexual Health Association (ASHA) and the Herpes Resource 
Center (HRC), patients are looking for reliable, current information about genital herpes 
(Alexander & Naisbett, 2002). Clients are seeking information about diagnostic testing, timing 
and accuracy of tests, and how the tests compare to one another (Alexander & Naisbett, 2002). 
They want to know about treatment strategies, including self-management, as well as available 
antiviral therapies, associated advantages and disadvantages, and effectiveness (Alexander & 
Naisbett, 2002). Patients are particularly concerned about the risk of herpes transmission and 
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which treatment strategies will prevent or reduce sexual transmission risk (Alexander & 
Naisbett, 2002).  
Among physicians surveyed, the focus seems to be on symptom management with a 
disregard for the psychological impact of genital herpes (Alexander & Naisbett, 2002). 
Treatments are based on cost effectiveness and the severity of clinical recurrences, ignoring 
disease transmission (Alexander & Naisbett, 2002). Physician’s attitudes towards genital herpes 
are alarming as half have no interest in the disease, do not offer any treatment, and are not 
interested in offering counseling to patients (Alexander & Naisbett, 2002). Therefore, a huge gap 
has formed between patient and physician perceptions about genital herpes (Alexander & 
Naisbett, 2002). A more recent article confirms that a gap still exists among health care providers 
and patients regarding attitudes and perceptions of genital herpes. Romanowski et al. (2008) 
administered an online survey to family doctors and patients with genital herpes in order to 
compare and contrast their attitudes and behaviors regarding the disease. According to the 
survey, doctors felt that they were more proactive and provided more information about genital 
herpes than was reported by patients (Romanowski et al., 2008). “Bridging the gap between 
patients and physicians is vital for improving the management of genital herpes” (Alexander, 
Naisbett, 2002, p. S57). Health care providers need to be better informed to best assist patients 
and to provide them with the information they are seeking. Knowledge about the disease, 
diagnosis, and treatment options is necessary to provide patients with accurate and appropriate 
information and supportive resources, and to help define their options (Alexander & Naisbett, 
2002). “This presents opportunities for education and improvement in the management of genital 
herpes” (Romanowski et al., 2008, p. 51).  
Behavior Change for Health Risk Reduction 
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A telephone survey conducted by Aral, Cates Jr., and Jenkins (1985) investigated 
whether awareness of the herpes epidemic leads to changes in sexual behavior. Of those 
surveyed, 45% who perceived themselves to be at risk for acquiring genital herpes expressed 
they had changed their behavior as a result of this perception (Aral et al., 1985). This data 
provides optimism regarding behavior change for health risk reduction (Aral et al., 1985). 
Though conducted in the past, these findings still remain true. Of 38 surveyed participants in a 
study conducted by Freeman, Zychowicz, Feldman, and Gordon (2012), 43.9% stated that 
screening alone led them to consider safer sexual practices. This is congruent with the findings of 
Aral et al. (1985), who found that a screening risk assessment alone led to increased reporting of 
safer sex practices. These findings suggest that with increased preventive education and 
counseling on genital herpes from health care providers, transmission of genital herpes and 
occurrences of neonatal herpes will be further minimized based on patients’ behavior changes.  
Educational Methods  
  Numerous interventions to educate health care providers have been proposed and tested 
throughout the literature.  
Meetings. Educational meetings, including courses, conferences, lectures, workshops, 
seminars, and symposia, are often used for continuing medical education (Forsetlund et al., 
2009). A review of eighty-one trials evaluating their effectiveness found that educational 
meetings, alone or combined with other interventions, can improve professional practice and the 
accomplishment of treatment goals by patients (Forsetlund et al., 2009). Higher attendance at 
meetings is linked to greater improvements in professional practice and patient outcomes 
(Forsetlund et al., 2009). Interactive combined with didactic educational methods are more 
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effective than either style alone (Forsetlund et al., 2009). Additionally, educational meetings 
alone are not likely to be effective for altering complex behaviors (Forsetlund et al., 2009).   
Printed materials. Printed educational materials are also often used to educate health 
care professionals. Printed educational materials (PEMs), in the form of research results 
published in health care journals and printed clinical practice guidelines distributed to health care 
providers, are widely used to increase knowledge, awareness, attitudes, skills, and professional 
practice of providers (process outcomes), and also to improve patient health outcomes (Farmer et 
al., 2008). PEMs can be dispersed to a large number of health care providers at a low cost 
(Farmer et al., 2008). A review of twenty-three studies found that PEMs alone, when compared 
to no intervention, may have an advantageous effect on healthcare professional practice (Farmer 
et al., 2008). There is insufficient evidence and a lack of results to determine whether PEMs, 
when compared to other interventions, have an impact on patient outcomes (Farmer et al., 2008).     
Internet-based modules. The use of web-based learning and educational modules to 
educate health care providers has also been reviewed. A study was conducted comparing a self-
learning web-based educational tool against a traditional on-campus lecture (Morente, Morales-
Asencio, & Veredas, 2013). Undergraduate nursing students educated on the topic of pressure 
ulcer assessment and treatment using the web-based tool showed profoundly higher learning 
acquisition (Morente et al., 2013). Morente et al. (2013) highlight that during traditional lecture-
based education, learners are “passive recipients of knowledge, showing low motivation and 
interest rates” (p. 2). In addition, there is no guarantee that learners are making the connection 
between theory and practice (Morente et al., 2013). On the other hand, web-based education 
allows flexible learning, available at any place and time, and provides immediate feedback 
(Morente et al., 2013). Web-based learning can also be applied to health care providers. Lehna, 
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Ramos, Myers, Coffey, and Kirk (2011) studied the effectiveness of a web-based educational 
module to increase knowledge regarding burn prevention. The 74-slide PowerPoint module 
proved to be an effective and convenient way to increase burn prevention knowledge 
immediately (recall) and over time (retention) (Lehna et al., 2011).  
With an increase in access to technology in the U.S., Internet use among health care 
providers is growing (Wutoh, Boren, & Balas, 2004; Cobb, 2004).  Wutoh et al. (2004) studied 
the relationships among Internet-based continuing education, provider’s performance, and 
patient outcomes. Advantages of web-based education include lower costs, convenience, 
increasingly interactive format, and ability to “complement and reinforce traditional medical 
teaching” (Wutoh et al., 2004, p. 21). Yet, according to Wutoh et al. (2004), attending meetings 
remains the desired format for physicians obtaining continuing education in the United States. 
Several studies were reviewed and it was determined that web-based continuing education 
programs are just as effective as printed materials or lecture-based education in transferring 
knowledge to health care providers (Wutoh et al., 2004).  
Similarly, Cobb (2004) reviewed studies regarding “practices, preferences, and 
evaluation of on-line continuing education used by health care professionals” (p. 171). Cobb 
(2004) also discovered that in-person continuing education is still the preferred and most 
common format, yet web-based continuing education is becoming increasingly popular. Those 
who participate in Internet-based continuing education find it to be an effective learning format 
and are pleased with the experience, yet barriers such as technical difficulties and lack of 
computer knowledge remain (Cobb, 2004). A more recent study by Cook et al. (2008) shares a 
consistent point of view regarding the benefits of internet-based learning and its increasing 
popularity. Cook et al. (2008) reviewed studies of web-based education involving healthcare 
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professionals and found that Internet-based learning, compared with no intervention, has a 
consistently positive effect. The effect of web-based instruction compared to non-Internet 
methods was inconsistent across studies, perhaps due to variation in learners and other 
characteristics of the educational framework (Cook et al., 2008). Nonetheless, web-based 
education is linked to favorable outcomes among a variety of learners, contexts, and topics, and 
seems to have effectiveness similar to traditional methods (Cook et al., 2008).       
Each of these strategies exists to educate health care professionals with varying learning 
styles and education needs. Educational meetings are most effective at improving professional 
practice and patient outcomes when content is presented in both an interactive and lecture format 
(Forsetlund et al., 2009). This education method may have the greatest benefit among older 
health care professionals who lack computer knowledge and prefer the in-person format. Web-
based educational modules have also shown significant learning acquisition and are 
advantageous because of their convenience, low cost, and interactive format (Morente et al., 
2013; Wutoh et al., 2004). Web-based learning most likely appeals to the younger generation of 
health care professionals who are technology savvy and prefer flexible learning opportunities. 
Printed educational materials (PEMs) are also an option when considering educational strategies 
for health care professionals. They are beneficial at increasing knowledge, awareness, attitudes, 
skills, and professional practice of providers (Farmer et al., 2008). PEMs are also useful because 
they allow review of the educational content following the completion of the educational 
meeting or web module. The March of Dimes offers educational opportunities for health 
professionals, including online material, modules, and conferences, which indicates that each of 
these interventions is applicable to genital herpes educational content (March of Dimes 
Foundation, 2014). Conclusively, an educational intervention was designed for an in-person 
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educational meeting, intended to be altered for use in additional educational formats, such as a 
web-based educational module or printed educational materials. This way, the content will have 
the most applicability and increase the knowledge of the greatest amount of health care 
professionals.   
Recommendations for Care: Educational Intervention 
 The educational intervention, Neonatal Herpes Prevention: Management Strategies 
During Pregnancy, is a 52-slide PowerPoint designed to inform health care professionals about 
genital herpes, its implications on the pregnant woman and neonate, and strategies for 
prevention, in order to minimize occurrences of neonatal herpes [see Appendix A, p. 38]. The 
presentation consists of lecture and interactive formats, as this combination is more effective 
than either style alone (Forsetlund et al., 2009). It is intended for use as a presentation during 
face-to-face educational meetings. The instructional format will allow the educator to clearly and 
concisely convey the material before questions are received from the audience (Price, 2010). The 
educational content can be applied to various educational formats, such as web-based learning 
modules or printed educational materials, tailored to providers’ diverse learning styles.  
 The presentation begins with three brief, measureable learning objectives allowing 
providers to form expectations about what they will gain from the educational meeting 
(Hoygaard, 2011). Each major section in the PowerPoint is led with an introduction title slide, 
permitting the learner to recognize and distinguish the content being presented. Interaction 
designed as “Test Your Knowledge” questions is included throughout the presentation, at the end 
of major sections. This emphasizes retention of material during the presentation, and serves as 
completion markers for each major section of the PowerPoint. 
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The educational content opens by explaining why genital herpes is important in an 
attempt to capture the learners’ attention (Price, 2010). Evidence is presented to further explain 
the need for health care providers to receive education on the topic. The presentation progresses 
through brief content regarding genital herpes: what it is, who is at risk for acquiring it, how it is 
transmitted, signs and symptoms, existing infection statuses, diagnostic testing, and treatment 
with antiviral therapy. This material is included to provide general information about genital 
herpes necessary to ensure health care providers are informed when counseling patients. The 
focus of the presentation shifts to genital herpes during pregnancy, including risk factors and 
characteristics of infection, and is followed by neonatal herpes, including what it is, how it is 
transmitted from mother to neonate, and prevention measures. Prevention techniques include 
assessment, screening, antiviral therapy, cesarean delivery, and education and counseling. The 
presentation concludes with two take home messages of importance and time is allotted for 
questions (Hoygaard, 2011).    
The PowerPoint design consists of text and background colors that provide a clear 
contrast and make the presentation easy to visualize (Price, 2010). A basic, large size font was 
chosen to further permit easy visualization. Simple transitions between slides are used in an 
attempt to keep the presentation timely and efficient (Price, 2010). Pictures are incorporated 
throughout the presentation to make effective use of space while minimizing distractions. 
Pictures are also included in an attempt to provide the learner with an additional tool to assist in 
retention and recall of material.  
The envisioned use for the educational intervention is as a continuing education course, 
specifically among health care providers caring for pregnant women or women of childbearing 
age. The goal is to inform professionals caring for this population about genital herpes and its 
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impact on the pregnant woman and neonate. The presentation is designed to give providers the 
knowledge necessary to counsel and educate their patients, the general public, regarding this 
disease. The expected outcome is behavior changes among those who perceive themselves at risk 
in order to prevent the acquisition of genital herpes, especially during pregnancy. Additionally, 
women and their partners will have a better understanding of how to manage genital herpes 
during pregnancy in order to reduce incidences of neonatal herpes.       
Next Steps: Implications for Future Practice 
Recommendations for the future are made to enhance nursing practice in the disease 
management and prevention of genital herpes. As previously mentioned, the educational 
intervention was designed for adaptation to various educational formats, such as a web-based 
learning module, and printed educational materials. This would be the next step in continuation 
of this project in order to meet providers’ unique learning needs and to ensure high applicability 
of the presentation. Prior to implementation, the educational content needs to be reviewed for 
applicability and use in the practice setting among providers. Additionally, a pretest and posttest 
should be designed in order to determine the presentation’s effectiveness at imparting knowledge 
onto health care professionals.        
Subsequent Presentation  
The educational intervention includes content to educate health care providers on genital 
herpes and its occurrence in pregnancy, neonatal herpes, and prevention strategies. The purpose 
of the educational intervention is to create informed health care providers, equipped to counsel 
patients on the prevention of genital herpes. While the focus of the intervention is on prevention, 
new cases of neonatal herpes are still occurring. Thus, providers also need to become educated 
regarding the phenomenon of neonatal herpes, how to recognize it, and appropriate measures to 
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take when infant exposure occurs. A similar presentation designed for adaption to varying 
educational formats can be used to further the established work, and can serve as a subsequent 
presentation in the continuing education course.        
Prospective Research 
Additional research is indicated on the topics of genital herpes during pregnancy, and 
neonatal herpes. The review of literature revealed varying guidelines recommended for the 
management of genital herpes in pregnancy. However, several questions remain regarding the 
effectiveness of these interventions in preventing the outcome of neonatal herpes. With 
additional research on the topics, authors and organizations can reach an agreement regarding the 
best way to manage genital herpes in pregnancy in order to decrease occurrences of neonatal 
herpes. Universal standards of nursing care can then be created regarding the optimal way to 
prevent neonatal herpes infections.            
Conclusion 
 Genital herpes is the most common sexually transmitted disease (STD) among the adult 
female population in the United States (Kriebs, 2008). Proper management of genital herpes 
among pregnant women and women of childbearing age, and their partners, is necessary to 
prevent the outcome of neonatal herpes. Knowledge regarding genital herpes is low among 
health care providers, suggesting that infected individuals, their partners, and those at risk for 
acquisition are receiving suboptimal and insufficient management and prevention guidance 
(Handsfield et al., 1998). Thus, as recommended by the CDC, a campaign to better educate 
health care providers and the general public about genital herpes and its prevention is necessary 
(Handsfield et al., 1998). An educational PowerPoint, Neonatal Herpes Prevention: Management 
Strategies During Pregnancy was designed for use in a face-to-face educational meeting, and 
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intended to be adapted to various educational formats to reach a high number of providers with 
different learning preferences. The goal of the educational intervention is to create informed 
health care providers, equipped with the knowledge necessary to counsel and educate their 
patients on genital herpes and its prevention. By ensuring that women and their partners receive 
accurate information necessary to manage the disease, providers are enabling expectant mothers 
to make informed decisions concerning their pregnancy and birth. The expected outcome is a 
reduction in cases of neonatal herpes as a result of increased knowledge among providers, 
patients and the general public, behavioral changes regarding sex practices, and better 
management of genital herpes.       
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Appendix A:  
Neonatal Herpes Prevention: Management Strategies During Pregnancy   
 
Please open the accompanying PowerPoint presentation or view the PowerPoint slides below. 
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